Nucleic acid aptamer aiming at micropterus salmoides virus and application of nucleic acid aptamer
Nucleic acid aptamers obtained through SELEX technology are used to construct molecular probes or detection kits, solving the problem of cumbersome virus detection methods that are cumbersome, time-consuming and cost-effective, and achieving rapid and accurate detection of largemouthome virus , reducing pathogen spread and economic losses.
Patent Information
- Application Number
- CN202411162428.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-22
- Publication Date
- 2024-11-26
AI Technical Summary
The existing largemouth bass virus detection methods are cumbersome, time-consuming and costly, and cannot meet the needs of fast and accurate on-site detection, resulting in the spread of pathogens and serious economic losses.
Develop a nucleic acid aptamer obtained by exponential enrichment ligand system evolution technology (SELEX) with high specificity and affinity, and is used to construct molecular probes or detection kits, combined with microplate reader and flow cytometer and other equipment to realize rapid detection of largemouth bass virus.
It realizes rapid, accurate and sensitive detection of largemouth bass virus, reduces detection cost and time, improves detection accuracy, and is suitable for use in farms.
Smart Images

Figure CN119020366A_ABST
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of bioengineering, and in particular relates to a nucleic acid aptamer targeting largemouth bass virus and application thereof. Background Art
[0002] Largemouth bass is a carnivorous fish with delicious meat, no intramuscular spines, fast growth, easy to catch, and wide temperature adaptability. It was introduced to Guangdong, my country in 1983, and artificially bred successfully in 1985, gradually becoming a famous and high-quality breeding variety. However, with the increase in the breeding density of largemouth bass and the expansion of breeding scale, various diseases have frequently broken out, causing huge economic losses. Among them, largemouth bass virus (LMBV) is the main viral pathogen that causes the disease of largemouth bass, with a very high mortality rate. Therefore, it is extremely important to develop a detection technology that is convenient to operate, low in cost, short in time, and high in accuracy to control the harm of largemouth bass virus. However, the current diagnostic methods for largemouth bass virus are mainly molecular biological detection methods and immunological detection methods, including PCR technology, nested PCR technology, fluorescent quantitative PCR technology, ELISA technology, etc. The detection results of PCR technology are accurate and reliable, but there are shortcomings such as cumbersome operation, long time consumption, and expensive instruments and reagents, which cannot meet the requirements of rapid and accurate on-site detection and diagnosis. Therefore, efforts should be made to develop rapid detection technologies and functional products for largemouth bass LMBV virus that are easy to operate, low in cost, short in time, highly accurate, and can be used on-site in farms. This is crucial for early detection and identification of pathogens, and then for developing targeted treatment plans to control the spread of pathogens and reduce losses.
[0003] Aptamers are single-stranded oligonucleotides that are obtained from artificially synthesized random sequence libraries through multiple rounds of in vitro screening using the Systematic Evolution of Ligands by Exponential Enrichment technology (SELEX) and can specifically recognize target substances. Aptamers have many advantages, such as high specificity, high affinity, strong stability, and easy chemical synthesis and chemical modification. Based on the biological characteristics of aptamers that can highly specifically recognize pathogenic microorganisms or diseased cells, aptamers are widely used in the development of detection technology and the construction of biosensors, and can achieve accurate detection and diagnosis of pathogens or diseases. Therefore, aptamers have broad application prospects in various fields of biology, such as disease diagnosis and research on viral infection mechanisms. Summary of the invention
[0004] The purpose of the present invention is to provide a nucleic acid aptamer for largemouth bass virus and application thereof, so as to improve the detection level of largemouth bass virus.
[0005] According to one aspect of the present invention, a nucleic acid aptamer for largemouth bass virus is provided, comprising a nucleotide sequence as shown in SEQ ID NO.1 and / or SEQ ID NO.2. Compared with existing protein antibodies, the nucleic acid aptamer provided by the present invention has higher affinity and specificity for largemouth bass virus (LMBV), and also has characteristics that protein antibodies do not have, including no immunogenicity, short preparation cycle, good reproducibility, small molecular weight, convenient in vitro chemical synthesis, convenient labeling, easy to modify and replace different parts of the nucleic acid aptamer, stable sequence, easy to transport and store, etc. Based on the nucleic acid aptamer provided by the present invention, the detection of largemouth bass virus can be realized simply and quickly, and a high accuracy and sensitivity can be achieved. The nucleic acid aptamer is used to construct a molecular probe or a detection kit, and combined with detection equipment such as an ELISA instrument, a flow cytometer, and a fluorescence microscope, the accurate detection of largemouth bass virus can be realized. This is of great significance for the rapid diagnosis of largemouth bass virus, and has good application prospects in the field of largemouth bass virus detection.
[0006] Preferably, the secondary structure of the nucleotide sequence shown in SEQ ID NO.2 is as follows:
[0007]
[0008] Preferably, a functional group is attached to the nucleotide sequence of the nucleic acid aptamer, and the functional group is selected from at least one of a biotin marker, a luminescent marker, and an enzyme marker.
[0009] According to another aspect of the present invention, there is provided a use of the above-mentioned nucleic acid aptamer for largemouth bass virus in the preparation of a product for detecting largemouth bass virus.
[0010] Preferably, the product is a detection kit.
[0011] Preferably, the product is a fluorescent molecular probe, and the nucleotide sequence of the nucleic acid aptamer is connected to a luminescent marker.
[0012] According to another aspect of the present invention, a fluorescent molecular probe is provided. The fluorescent molecular probe comprises the above-mentioned nucleic acid aptamer for largemouth bass virus, and a luminescent marker is connected to the nucleotide sequence of the nucleic acid aptamer.
[0013] According to another aspect of the present invention, a detection kit is provided, which comprises the above-mentioned nucleic acid aptamer against largemouth bass virus. BRIEF DESCRIPTION OF THE DRAWINGS
[0014] Figure 1 This is a predicted secondary structure diagram of the nucleic acid aptamer whose nucleotide sequence is shown as SEQ ID NO.2 in Example 1 of the present invention.
[0015] Figure 2 The results of flow cytometer detection of CY5 fluorescence intensity in experimental group 1 and control group 1 in Example 2 of the present invention are shown.
[0016] Figure 3 These are the observation results of the laser scanning confocal microscope on the experimental group 2 and the control group 2 in Example 2 of the present invention. DETAILED DESCRIPTION
[0017] In order to enable those skilled in the art to better understand the solutions of the present invention, the technical solutions in the embodiments of the present invention will be clearly and completely described below. Obviously, the described embodiments are only embodiments of a part of the present invention, rather than all embodiments.
[0018] Example 1 Screening and preparation of nucleic acid aptamers for LMBV
[0019] S1. Construction of the first ssDNA library and synthesis of primers
[0020] The first ssDNA library Library 50 was designed and synthesized, and its nucleotide sequence was as follows: 5'-GACGCTTACTCAGGTGTGACTCG(50N)CGAAGGACGCAGATGAAGTCTC-3', wherein both ends were fixed sequences and the middle 50 nucleotides were random sequences.
[0021] The upstream primer includes the DNA sequence shown in SEQ ID NO. 3 and is labeled with hydroxyfluorescein (CY5), and its specific sequence is: 5'-CY5-GACGCTTACTCAGGTGTGACTCG-3'.
[0022] The downstream primer includes the DNA sequence shown in SEQ ID NO. 4 and is labeled with biotin. The specific sequence is: 5'-Biotin-GAGACTTCATCTGCGTCCTTCG-3'.
[0023] The first ssDNA library and primers were synthesized by Shanghai Sangon Biotechnology Co., Ltd.
[0024] S2. SELEX screening to obtain nucleic acid aptamers that specifically recognize FHM cells infected with LMBV (positive screening)
[0025] S2.1 10 nmol of the first ssDNA library was dissolved in 500 μL PBS, and the mixture was kept in a constant temperature water bath at 92°C for 5 min, and then quickly placed in ice for 10 min. The treated first ssDNA library was incubated with fathead mullet muscle cells (FHM cells) infected with largemouth bass virus (LMBV) on ice for 1 h.
[0026] S2.2 After incubation and binding, remove the supernatant by centrifugation, wash the LMBV-infected FHM cells with 10 mL of PBS, place in a 92°C constant temperature water bath for 10 min, and collect the supernatant by centrifugation at 12,000 g, which is the second ssDNA library that specifically identifies cells infected with LMBV.
[0027] S3. PCR amplification
[0028] Take 100 μL of the second ssDNA library obtained by screening and perform PCR amplification with the upstream primer and the downstream primer. The PCR reaction system is as follows (1000 μL): 10×Buffer 100 μL, dNTP Mix (2.5 mM) 80 μL, upstream primer 40 μL, downstream primer 40 μL, second ssDNA library 100 μL, rTaq enzyme 12.5 μL, ddH2O 627.5 μL. Perform PCR amplification according to the following procedure: 92°C for 5 minutes, 92°C for 1 minute, 60°C for 30 seconds, 72°C for 1 minute, after 25 cycles; 72°C for 5 minutes. The supernatant obtained after the first round of cyclic screening should be used for subsequent PCR amplification to obtain the amplified dsDNA library.
[0029] S4. Preparation of the third ssDNA library
[0030] 100 μL of streptavidin-labeled magnetic beads were incubated with the dsDNA library at room temperature for 20 minutes. The dsDNA library was bound to the surface of the magnetic beads by the affinity between the biotin on the dsDNA library and the streptavidin on the magnetic beads. The supernatant was removed by a magnetic separator, and the magnetic beads were washed with 2 mL of PBS. Then 200 μL of NaOH solution (200 mM) was added to the EP tube and reacted at room temperature for 10 minutes to denature and melt the dsDNA library. One chain with biotin was bound to the streptavidin and remained on the magnetic beads. The single-stranded DNA bound to the magnetic beads was used as the third ssDNA library. The supernatant was recovered by a magnetic separation rack. After the desalting column was washed with 10 mL of sterile water, the supernatant was added to the desalting column and dripped naturally by gravity. 500 μL of PBS was added, and the collected solution was used for the next round of screening.
[0031] S5. Repeated screening
[0032] The third ssDNA library obtained in S4 was used to replace the first ssDNA library, and the positive screening process, PCR amplification and single-stranded DNA library preparation process shown in S2 to S4 were repeated 10 times.
[0033] S6. Negative screening
[0034] In the second round of S5 and subsequent rounds of screening, normal FHM cells were used as controls, and the ssDNA library obtained after S5 screening was negatively screened to improve the screening efficiency. The specific negative screening process is: the ssDNA library obtained by screening was dissolved, and incubated with normal FHM cells on ice for 1 hour in a constant temperature water bath at 92°C. After the incubation was completed, the supernatant solution was collected by centrifugation, which was the ssDNA library that had undergone negative screening.
[0035] S7.11 round screening
[0036] The supernatant containing the ssDNA library was collected in S6, and after PCR amplification in S3 and ssDNA library preparation in S4, the processes of S6, S2, S3 and S4 were repeated in sequence, and the change in the recognition ability of the obtained ssDNA library to LMBV-infected cells was detected by flow cytometry. The screening was repeated for 6 rounds, and the ssDNA library obtained at this time had the strongest recognition ability to LMBV-infected cells. The obtained amplified product was cloned and sequenced to finally obtain the nucleic acid aptamer for largemouth bass virus (LMBV) in this embodiment, and its nucleotide sequence was:
[0037] TGGCACGCCACAACGAAGGGCATAGTTCAGCCCCAATACCAACGTCGCTT(SEQ IN NO.1),
[0038] or,
[0039] GACGCTTACTCAGGTGTGACTCGACACCCAAATTCCGTCAGTCGTGCTCGT AATTCACAACACCGCTGGCCATCGAAGGACGCAGATGAAGTCTC (SEQ ID NO. 2).
[0040] The secondary structure of SEQ ID NO. 2 was predicted online using MFOLD software (http: / / mfold.rna.albany.edu / ?q=mfold / DNA-Folding-Form). The prediction results are as follows: Figure 1 As shown by Figure 1 It can be seen that the nucleic acid aptamer with a nucleotide sequence as shown in SEQ ID NO.2 forms a special stem-loop structure and a hairpin structure, and its Gibbs free energy (ΔG) is -10.01. Similarly, the nucleic acid aptamer with a nucleotide sequence as shown in SEQ ID NO.1 also forms a special stem-loop structure and a hairpin structure.
[0041] Example 2 Verification of the binding effect of nucleic acid aptamers on FHM cells infected with LMBV
[0042] 1. Main instruments
[0043] Attune NxT flow cytometer (Thermo Fisher Scientific), FV3000 laser scanning confocal microscope (Olympus).
[0044] 2. Experimental Methods
[0045] (1) Grouping
[0046] The nucleic acid aptamers with nucleotide sequences as shown in SEQ ID NO.1 and SEQ ID NO.2 constructed in Example 1 were respectively labeled with cyanine dye (CY5).
[0047] Experimental group 1: 10 nmol of SEQ ID NO.1 nucleic acid aptamer was dissolved in 500 μL PBS, incubated in a 92°C constant temperature water bath for 5 min, and then quickly inserted into ice and incubated for 10 min. The treated nucleic acid aptamer was incubated with FHM cells infected with LMBV (FHM cells were stained with Hoechst dye Hoechst 33342) on ice for 1 h. After the incubation and binding were completed, the supernatant was removed by centrifugation.
[0048] Control group 1: 10 nmol of SEQ ID NO.1 nucleic acid aptamer was dissolved in 500 μL PBS, kept in a constant temperature water bath at 92°C for 5 min, and then quickly inserted into ice and kept in an ice bath for 10 min. The treated nucleic acid aptamer was incubated with normal FHM cells (FHM cells were stained with Hoechst dye Hoechst 33342) on ice for 1 h. After the incubation and binding were completed, the supernatant was removed by centrifugation.
[0049] Experimental group 2: 10 nmol of SEQ ID NO.2 nucleic acid aptamer was dissolved in 500 μL PBS, incubated in a 92°C constant temperature water bath for 5 min, and then quickly inserted into ice and incubated for 10 min. The treated nucleic acid aptamer was incubated with FHM cells infected with LMBV (FHM cells were stained with Hoechst dye Hoechst 33342) on ice for 1 h. After the incubation and binding were completed, the supernatant was removed by centrifugation.
[0050] Control group 2: 10 nmol of SEQ ID NO.2 nucleic acid aptamer was dissolved in 500 μL PBS, incubated in a 92°C constant temperature water bath for 5 min, and then quickly inserted into ice for 10 min. The treated nucleic acid aptamer was incubated with normal FHM cells (FHM cells were stained with Hoechst dye Hoechst 33342) on ice for 1 h. After the incubation and binding were completed, the supernatant was removed by centrifugation.
[0051] (2) Detection
[0052] Flow cytometry was used to detect the binding effect and specificity of nucleic acid aptamer (SEQ ID NO.1) with FHM cells in experimental group 1 and control group 1, respectively.
[0053] The cell precipitates obtained after incubation of the nucleic acid aptamer (SEQ ID NO. 2) and FHM cells in the experimental group 2 and the control group 2 were observed using a laser confocal microscope.
[0054] 3. Experimental results
[0055] The results of flow cytometry were as follows Figure 2 As shown, the results confirmed that the fluorescence value detected by flow cytometry on the surface of FHM cells infected with LMBV in experimental group 1 was significantly higher than that in control group 1. This shows that the nucleic acid aptamer (SEQ ID NO.1) provided by the present invention has a high specific recognition ability for FHM cells infected with LMBV.
[0056] The results of laser confocal microscopy are shown in Figure 3 As shown, the results confirmed that compared with the control group 2, the experimental group 2 showed obvious red fluorescence. This shows that the nucleic acid aptamer (SEQ ID NO. 2) provided by the present invention can bind to the surface of FHM cells infected with LMBV, that is, it has a high specific recognition ability for FHM cells infected with LMBV.
[0057] The above embodiments are only used to illustrate the technical solution of the present invention rather than to limit the protection scope of the present invention. Although the present invention has been described in detail with reference to the preferred embodiments, those skilled in the art should understand that the technical solution of the present invention can be modified or replaced by equivalents without departing from the essence and scope of the technical solution of the present invention.
Claims
1. A nucleic acid aptamer for largemouth bass virus, characterized in that: It includes the nucleotide sequence shown as SEQ ID NO.1 and / or SEQ ID NO.
2.
2. The nucleic acid aptamer for largemouth bass virus according to claim 1, characterized in that: The secondary structure of the nucleotide sequence shown in SEQ ID NO.2 is as follows:
3. The nucleic acid aptamer for largemouth bass virus according to claim 1 or 2, characterized in that: The nucleotide sequence of the nucleic acid aptamer is connected with a functional group, and the functional group is selected from at least one of a biotin marker, a luminescent marker, and an enzyme marker.
4. Use of the nucleic acid aptamer against largemouth bass virus according to any one of claims 1 to 3 in the preparation of a product for detecting largemouth bass virus.
5. Use of the nucleic acid aptamer for largemouth bass virus as claimed in claim 4 in preparing a product for detecting largemouth bass virus, characterized in that: The product is a detection kit.
6. Use of the nucleic acid aptamer for largemouth bass virus as claimed in claim 4 in preparing a product for detecting largemouth bass virus, characterized in that: The product is a fluorescent molecular probe, and a luminescent marker is connected to the nucleotide sequence of the nucleic acid aptamer.
7. A fluorescent molecular probe, characterized in that: The invention comprises the nucleic acid aptamer for largemouth bass virus as claimed in any one of claims 1 to 3, wherein the nucleotide sequence of the nucleic acid aptamer is connected with a luminescent marker.
8. A detection kit, characterized in that: The invention comprises the nucleic acid aptamer against largemouth bass virus as claimed in any one of claims 1 to 3.
